| Name | Title | Contact Details |
|---|---|---|
Matthew Hills |
Director of Financial Planning and Analysis | Profile |
Jeffrey Scott |
Vice President Supply Chain and Procurement | Profile |
Shailesh Raichura |
VP, R&D Software Development RTSM & Supplies | Profile |
Wade Wirta |
Vice President, Product Enablement | Profile |
Spencer Jones |
Sr. Vice President - Global Head of Product for Digital Trials | Profile |
There are three Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis. Otsuka Maryland Medicinal Laboratories, Inc. (OMML) is a basic research center investigating pharmacological compounds.
ParagonRx is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents for various diseases screening and monitoring.
Fluidx Medical Technologys novel GPX Embolic Device is a durable embolic that is easy to use, controllable, and effective for vessel occlusion.